JOURNAL OF PERIODONTOLOGY, vol.79, no.10, pp.1950-1961, 2008 (SCI-Expanded)
Background: The present study was designed to evaluate the effects of risedronate, one of the most potent bisphosphonates, on alveolar bone resorption and angiogenesis in rats with experimental periodontitis to identify dose-response curves and treatment durations that can be therapeutic for periodontal therapy versus those associated with osteonecrosis of the jaws.